PROVIDENCE, R.I. and PARIS--(BUSINESS WIRE)--Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in oncology, and Ariana Pharmaceuticals SA, a developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and breast cancers and to the clinical outcome of patients with these diseases through the analysis of public genome databases.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
